Published Date:2021-12-03 Original Link:https://www.onenessbio.com/en/news_detail127_1.htm No 1 Date of announcement 2021/12/03 Time of announcement 16:56:09 Subject The mechanism of action and Phase 3 MRCT results of the diabetic foot ulcer new drug, Fespixon have been accepted for an oral presentation at IDF Congress 2021 To which item it meets paragraph 12 Date of events 2021/12/03 Statement...Read More